Articles with public access mandates - Abdel Kareem AzabLearn more
Not available anywhere: 2
Fatty acid binding proteins in multiple myeloma
C Diedrich, M Maksimos, AK Azab
Trends in Molecular Medicine 29 (8), 584-585, 2023
Mandates: Cancer Prevention Research Institute of Texas, USA
Targeted Cancer Immunotherapy by Nanoparticle T Cell Engagers
B Lubben, K Alhallak, J Sun, B Muz, H Bash, C Park, O Adebayo, ...
The FASEB Journal 36, 2022
Mandates: US National Institutes of Health
Available somewhere: 73
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
AM Roccaro, A Sacco, P Maiso, AK Azab, YT Tai, M Reagan, F Azab, ...
The Journal of clinical investigation 123 (4), 1542-1555, 2013
Mandates: US National Institutes of Health
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
AK Azab, JM Runnels, C Pitsillides, AS Moreau, F Azab, X Leleu, X Jia, ...
Blood, The Journal of the American Society of Hematology 113 (18), 4341-4351, 2009
Mandates: US National Institutes of Health
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
AM Roccaro, A Sacco, B Thompson, X Leleu, AK Azab, F Azab, J Runnels, ...
Blood, The Journal of the American Society of Hematology 113 (26), 6669-6680, 2009
Mandates: US National Institutes of Health
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
AK Azab, J Hu, P Quang, F Azab, C Pitsillides, R Awwad, B Thompson, ...
Blood, The Journal of the American Society of Hematology 119 (24), 5782-5794, 2012
Mandates: US National Institutes of Health, Research Foundation (Flanders)
Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion
P Neri, L Ren, AK Azab, M Brentnall, K Gratton, AC Klimowicz, C Lin, ...
Blood, The Journal of the American Society of Hematology 117 (23), 6202-6213, 2011
Mandates: US National Institutes of Health
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma
S Blotta, J Jakubikova, T Calimeri, AM Roccaro, N Amodio, AK Azab, ...
Blood, The Journal of the American Society of Hematology 120 (25), 5002-5013, 2012
Mandates: US National Institutes of Health
Spotlight on ixazomib: potential in the treatment of multiple myeloma
B Muz, RN Ghazarian, M Ou, MJ Luderer, HD Kusdono, AK Azab
Drug design, development and therapy, 217-226, 2016
Mandates: US National Institutes of Health
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia
HT Ngo, X Leleu, J Lee, X Jia, M Melhem, J Runnels, AS Moreau, ...
Blood, The Journal of the American Society of Hematology 112 (1), 150-158, 2008
Mandates: US National Institutes of Health
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib
E Weisberg, AK Azab, PW Manley, AL Kung, AL Christie, R Bronson, ...
Leukemia 26 (5), 985-990, 2012
Mandates: US National Institutes of Health
3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma
P de la Puente, B Muz, RC Gilson, F Azab, M Luderer, J King, S Achilefu, ...
Biomaterials 73, 70-84, 2015
Mandates: US National Institutes of Health
microRNA-dependent modulation of histone acetylation in Waldenström macroglobulinemia
AM Roccaro, A Sacco, X Jia, AK Azab, P Maiso, HT Ngo, F Azab, ...
Blood, The Journal of the American Society of Hematology 116 (9), 1506-1514, 2010
Mandates: US National Institutes of Health
RhoA and Rac1 GTPases play major and differential roles in stromal cell–derived factor-1–induced cell adhesion and chemotaxis in multiple myeloma
AK Azab, F Azab, S Blotta, CM Pitsillides, B Thompson, JM Runnels, ...
Blood, The Journal of the American Society of Hematology 114 (3), 619-629, 2009
Mandates: US National Institutes of Health
Targeting NF-κB in Waldenstrom macroglobulinemia
X Leleu, J Eeckhoute, X Jia, AM Roccaro, AS Moreau, M Farag, A Sacco, ...
Blood, The Journal of the American Society of Hematology 111 (10), 5068-5077, 2008
Mandates: US National Institutes of Health
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia
AM Roccaro, A Sacco, C Chen, J Runnels, X Leleu, F Azab, AK Azab, ...
Blood, The Journal of the American Society of Hematology 113 (18), 4391-4402, 2009
Mandates: US National Institutes of Health
P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment
AK Azab, P Quang, F Azab, C Pitsillides, B Thompson, T Chonghaile, ...
Blood, The Journal of the American Society of Hematology 119 (6), 1468-1478, 2012
Mandates: US National Institutes of Health
Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenström's macroglobulinemia
IM Ghobrial, A Roccaro, F Hong, E Weller, N Rubin, R Leduc, M Rourke, ...
Clinical Cancer Research 16 (3), 1033-1041, 2010
Mandates: US National Institutes of Health
Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia
AM Roccaro, A Sacco, EN Husu, C Pitsillides, S Vesole, AK Azab, F Azab, ...
Blood, The Journal of the American Society of Hematology 115 (3), 559-569, 2010
Mandates: US National Institutes of Health
Drug delivery approaches for the treatment of cervical cancer
F Ordikhani, M Erdem Arslan, R Marcelo, I Sahin, P Grigsby, JK Schwarz, ...
Pharmaceutics 8 (3), 23, 2016
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program